Misghina Weldegiorgis

Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and Nephropathy

Misghina Weldegiorgis, Dick de Zeeuw, Liang Li et al. · American Journal of Kidney Diseases · 2017 · 72 citations · Full text

Medicine, Biostatistics, Nephrology +14

Estimated GFR Decline as a Surrogate End Point for Kidney Failure: A Post Hoc Analysis From the Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) Study and Irbesartan Diabetic Nephropathy Trial (IDNT)

Hiddo J.L. Heerspink, Misghina Weldegiorgis, Lesley A. Inker et al. · American Journal of Kidney Diseases · 2013 · 67 citations

Medicine, Nephrology, Pharmacotherapy +17

Changes in GFR and Albuminuria in Routine Clinical Practice and the Risk of Kidney Disease Progression

Brendon L. Neuen, Misghina Weldegiorgis, William G. Herrington et al. · American Journal of Kidney Diseases · 2021 · 60 citations

Medicine, Nephrology, Renal Pathophysiology +12

Elevated triglycerides and reduced high-density lipoprotein cholesterol are independently associated with the onset of advanced chronic kidney disease: a cohort study of 911,360 individuals from the United Kingdom

Misghina Weldegiorgis, Mark Woodward · BMC Nephrology · 2022 · 34 citations · Full text

Public Health, Nephrology, Clinical Epidemiology +11

Socioeconomic disadvantage and the risk of advanced chronic kidney disease: results from a cohort study with 1.4 million participants

Misghina Weldegiorgis, Margaret Smith, William G. Herrington et al. · Nephrology Dialysis Transplantation · 2019 · 33 citations

Medicine, Nephrology, Health Demography +14